Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring

Autore, 2002, Risk associated with pregnancy in hypertrophic cardiomyopathy, J Am Coll Cardiol, 40, 1864, 10.1016/S0735-1097(02)02495-6 Maron, 2016, Contemporary Strategies for Risk Stratification and Prevention of Sudden Death with the Implantable Defibrillator in Hypertrophic Cardiomyopathy, Heart Rhythm, 10.1016/j.hrthm.2015.12.048 Bos, 2010, Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy, Am J Cardiol, 106, 1481, 10.1016/j.amjcard.2010.06.077 Duvekot, 1994, Maternal cardiovascular hemodynamic adaptation to pregnancy, Obstet Gynecol Surv, 49, S1, 10.1097/00006254-199412011-00001 Moertl, 2009, Changes in haemodynamic and autonomous nervous system parameters measured non-invasively throughout normal pregnancy, Eur J Obstet Gynecol Reprod Biol., 144Suppl1, S179, 10.1016/j.ejogrb.2009.02.037 Pieper, 2013, Pregnancy in women with hypertrophic cardiomyopathy, Neth Heart J, 21, 14, 10.1007/s12471-012-0358-7 Francia, 2014, Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy, J Cardiovas Electrophysiol, 25, 1180, 10.1111/jce.12492